[1]. Kalsch, H., et al., Association of progressive thoracic aortic calcification with future cardiovascular events and all-cause mortality: ability to improve risk prediction? Results of the Heinz Nixdorf Recall (HNR) study. Eur Heart J Cardiovasc Imaging, 2019. 20(6): p. 709-717.
[2]. Lehmann, N., et al., Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events: Result of the HNR Study (Heinz Nixdorf Recall). Circulation, 2018. 137(7): p. 665-679.
[3]. Zhou, D., et al., Irregular surface of carotid atherosclerotic plaque is associated with ischemic stroke: a magnetic resonance imaging study. J Geriatr Cardiol, 2019. 16(12): p. 872-879.
[4]. Song, P., et al., Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health, 2020. 8(5): p. e721-e729.
[5]. Piepoli, M.F., et al., 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J, 2016. 37(29): p. 2315-2381.
[6]. Yang, C.W., et al., Subclinical Atherosclerosis Markers of Carotid Intima-Media Thickness, Carotid Plaques, Carotid Stenosis, and Mortality in Community-Dwelling Adults.Int J Environ Res Public Health, 2020. 17(13).
[7]. Zhao, Q., et al., LDL-C:HDL-C ratio and common carotid plaque in Xinjiang Uygur obese adults: a cross-sectional study. BMJ Open, 2018. 8(10): p. e022757.
[8]. Guo, X., et al., An update on overweight and obesity in rural Northeast China: from lifestyle risk factors to cardiometabolic comorbidities. BMC Public Health, 2014. 14: p. 1046.
[9]. Skinner, A.C., et al., Cardiometabolic Risks and Severity of Obesity in Children and Young Adults. N Engl J Med, 2015. 373(14): p. 1307-17.
[10]. Cai, L., et al., Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China. J Atheroscler Thromb, 2012. 19(2): p. 159-68.
[11]. Valensi, P., et al., Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol, 2016. 15(1): p. 104.
[12]. Packard, C.J., et al., Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation, 2005. 112(20): p. 3058-65.
[13]. Endo, A., et al., Contributors to newly developed coronary artery disease in patients with a previous history of percutaneous coronary intervention beyond the early phase of restenosis. Intern Med, 2014. 53(8): p. 819-28.
[14]. Kunutsor, S.K., et al., Is High Serum LDL/HDL Cholesterol Ratio an Emerging Risk Factor for Sudden Cardiac Death? Findings from the KIHD Study. J Atheroscler Thromb, 2017. 24(6): p. 600-608.
[15]. Matsumoto, I., et al., Impact of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention. Circ J, 2011. 75(4): p. 905-10.
[16]. Zhong, Z., et al., Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation. Lipids Health Dis, 2019. 18(1): p. 40.
[17]. Yu, Y., et al., A U-shaped association between the LDL-cholesterol to HDL-cholesterol ratio and all-cause mortality in elderly hypertensive patients: a prospective cohort study. Lipids Health Dis, 2020. 19(1): p. 238.
[18]. Liu, L., et al., Association of LDL-C/HDL-C Ratio With Stroke Outcomes Within 1 Year After Onset: A Hospital-Based Follow-Up Study. Front Neurol, 2020. 11: p. 408.
[19]. You, S., et al., LDL-C/HDL-C ratio and risk of all-cause mortality in patients with intracerebral hemorrhage. Neurol Res, 2016. 38(10): p. 903-8.
[20]. Shinkawa, Y., et al., Mathematical modeling for the prediction of cerebral white matter lesions based on clinical examination data. PloS one, 2019. 14(4): p. e0215142-e0215142.
[21]. Zhang, H., et al., Associations between Carotid Artery Plaque Score, Carotid Hemodynamics and Coronary Heart Disease. Int J Environ Res Public Health, 2015. 12(11): p. 14275-84.
[22]. Piepoli, M.F., et al., 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J, 2016. 37(29): p. 2315-2381.
[23]. Bhanpuri, N.H., et al., Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study. Cardiovasc Diabetol, 2018. 17(1): p. 56.
[24]. Valensi, P., et al., Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol, 2016. 15(1): p. 104.
[25]. Lou, Y., et al., LDL-cholesterol to HDL-cholesterol ratio discordance with lipid parameters and carotid intima-media thickness: a cohort study in China. Lipids Health Dis, 2020. 19(1): p. 141.
[26]. Qin, P., et al., Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Ratio and Carotid Intima-Media Thickness: A Cohort Study in China. Lipids, 2021. 56(1): p. 59-68.
[27]. Enomoto, M., et al., LDL-C/HDL-C Ratio Predicts Carotid Intima-Media Thickness Progression Better Than HDL-C or LDL-C Alone. J Lipids, 2011. 2011: p. 549137.
[28]. Varma, V., et al., Serum Total Sialic Acid and Highly Sensitive C-reactive Protein: Prognostic Markers for the Diabetic Nephropathy. J Lab Physicians, 2016. 8(1): p. 25-9.
[29]. Zhong, Z., et al., Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation. Lipids Health Dis, 2019. 18(1): p. 40.
[30]. Umeda, T., et al., Low-Density Lipoprotein Cholesterol Goal Attainment Rates by Initial Statin Monotherapy Among Patients With Dyslipidemia and High Cardiovascular Risk in Japan- A Retrospective Database Analysis. Circ J, 2018. 82(6): p. 1605-1613.
[31]. Manninen, V., et al., Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation, 1992. 85(1): p. 37-45.
[32]. Katakami, N., et al., Usefulness of lipoprotein ratios in assessing carotid atherosclerosis in Japanese type 2 diabetic patients. Atherosclerosis, 2011. 214(2): p. 442-7.
[33]. Wu, T.W., et al., Associations of Cardiovascular Risk Factors with Carotid Intima-Media Thickness in Middle-Age Adults and Elders. J Atheroscler Thromb, 2017. 24(7): p. 677-686.
[34]. Nimkuntod, P. and P. Tongdee, Plasma Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Concentration Ratio and Early Marker of Carotid Artery Atherosclerosis. J Med Assoc Thai, 2015. 98 Suppl 4: p. S58-63.
[35]. Qin, P., et al., Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Ratio and Carotid Intima-Media Thickness: A Cohort Study in China. Lipids, 2021. 56(1): p. 59-68.